@article{oai:nagasaki-u.repo.nii.ac.jp:00027458,
 author = {Ogawa, Koki and Kato, Naoya and Yoshida, Michiharu and Hiu, Takeshi and Matsuo, Takayuki and Mizukami, Shusaku and Omata, Daiki and Suzuki, Ryo and Maruyama, Kazuo and Mukai, Hidefumi and Kawakami, Shigeru},
 journal = {Journal of Controlled Release},
 month = {Jun},
 note = {Messenger RNA (mRNA) medicine has become a new therapeutic approach owing to the progress in mRNA delivery technology, especially with lipid nanoparticles (LNP). However, mRNA encapsulated-LNP (mRNA-LNP) cannot spontaneously cross the blood-brain barrier (BBB) which prevents the expression of foreign proteins in the brain. Microbubble-assisted focused ultrasound (FUS) BBB opening is an emerging technology that can transiently enhance BBB permeability. In this study, FUS/microbubble-assisted BBB opening was investigated for the intravenous delivery of mRNA LNP to the brain. The intensity of FUS irradiation was optimized to 1.5 kW/cm2, at which BBB opening occurred efficiently without hemorrhage or edema. Exogenous protein (luciferase) expression by mRNA-LNP, specifically at the FUS-irradiated side of the brain, occurred only when FUS and microbubbles were applied. This exogenous protein expression was faster but shorter than that of plasmid DNA delivery. Furthermore, foreign protein expression was observed in the microglia, along with CD31-positive endothelial cells, whereas no expression was observed in astrocytes or neurons. These results support the addition of mRNA-LNP to the lineup of nanoparticles delivered by BBB opening., Journal of Controlled Release, 348, pp. 34-41; 2022},
 pages = {34--41},
 title = {Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain},
 volume = {348},
 year = {2022}
}